Shares of Palatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $22.33 and traded as high as $24.42. Palatin Technologies shares last traded at $24.42, with a volume of 11 shares.
Palatin Technologies Stock Performance
The firm’s fifty day simple moving average is $24.49 and its 200 day simple moving average is $22.35. The firm has a market cap of $962,400.00, a P/E ratio of -15.52 and a beta of -1.56.
About Palatin Technologies
Palatin Technologies, Inc is a biopharmaceutical company focused on developing medicines that target melanocortin receptors, a group of receptors involved in regulating appetite, sexual function, inflammation, and other physiological processes. The company’s research programs are intended to address conditions in areas such as obesity, sexual dysfunction, inflammatory disease, and related disorders.
Palatin’s best-known product is Vyleesi (bremelanotide), a melanocortin receptor agonist approved by the U.S.
Recommended Stories
- Five stocks we like better than Palatin Technologies
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
